BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29187372)

  • 21. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.
    Pistrosch F; Herbrig K; Kindel B; Passauer J; Fischer S; Gross P
    Diabetes; 2005 Jul; 54(7):2206-11. PubMed ID: 15983223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
    Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
    Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel roles of the renal angiotensin-converting enzyme.
    Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
    Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system.
    Clotet S; Soler MJ; Rebull M; Gimeno J; Gurley SB; Pascual J; Riera M
    J Hypertens; 2016 Sep; 34(9):1752-65. PubMed ID: 27379538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
    Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
    Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
    Parving HH; Andersen S; Jacobsen P; Christensen PK; Rossing K; Hovind P; Rossing P; Tarnow L
    Semin Nephrol; 2004 Mar; 24(2):147-57. PubMed ID: 15017527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy.
    Mizuiri S; Yoshikawa H; Tanegashima M; Miyagi M; Kobayashi M; Sakai K; Hayashi I; Aikawa A; Ohara T; Hasegawa A
    Am J Kidney Dis; 1998 Feb; 31(2):301-7. PubMed ID: 9469501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin induces CD44 expression in glomerular parietal epithelial cells by activating extracellular signal-regulated kinase 1/2 pathway.
    Zhao X; Chen X; Chima A; Zhang Y; George J; Cobbs A; Emmett N
    J Cell Physiol; 2019 May; 234(5):7224-7235. PubMed ID: 30362534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
    Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
    J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
    Satchell SC; Tooke JE
    Diabetologia; 2008 May; 51(5):714-25. PubMed ID: 18347777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.
    Soler MJ; Wysocki J; Ye M; Lloveras J; Kanwar Y; Batlle D
    Kidney Int; 2007 Sep; 72(5):614-23. PubMed ID: 17579661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
    Chang SY; Chen YW; Chenier I; Tran Sle M; Zhang SL
    Exp Diabetes Res; 2011; 2011():521076. PubMed ID: 22110472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
    El Boustany R; Taveau C; Chollet C; Velho G; Bankir L; Alhenc-Gelas F; Roussel R; Bouby N
    J Diabetes Complications; 2017 Jun; 31(6):929-932. PubMed ID: 28412033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.
    Fabris B; Candido R; Carraro M; Fior F; Artero M; Zennaro C; Cattin MR; Fiorotto A; Bortoletto M; Millevoi C; Bardelli M; Faccini L; Carretta R
    Diabetes; 2001 Nov; 50(11):2619-24. PubMed ID: 11679443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
    Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.